LAS VEGAS, NV--(Marketwired - Apr 22, 2014) - Alkame Holdings, Inc. (
Robert K. Eakle, CEO of Alkame Holdings, Inc., commented, "The addition of three experienced beverage industry veterans to Alkame's current sales team will not only expand our regional sales footprint, but will also help to accelerate Alkame's overall national distribution strategy."
The new Alkame regional sales managers will provide additional coverage to three distinct distribution territories -- the Midwest (Illinois, Indiana, Iowa, Kentucky, Michigan, Missouri, Ohio, Wisconsin, and Pennsylvania), the Southeast (Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, and Tennessee), and the Southwest (Arizona, California, Colorado, New Mexico, Nevada, Texas and Utah).
Mr. Eakle concluded, "I am very confident that their regional professional sales experience and beverage industry specific connections make them ideally suited to help grow Alkame to its full potential and into a national household brand."
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame's patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. The patented Alkame technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
Not all waters are created equal™. For more information, visit www.alkamewater.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that the Company will release additional bottle sizes and expand distribution for the Company's products, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.